<!DOCTYPE html>
<html lang="pt-BR">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Novo Nordisk Stock Intelligence | NVO Analysis</title>
  <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
  <style>
    :root {
      --bg-primary: #0a0f1a;
      --bg-gradient: radial-gradient(ellipse 150% 80% at 20% -20%, #1e3a5f 0%, #0d1526 50%, #080c14 100%);
      --glass-bg: rgba(255,255,255,0.03);
      --glass-border: rgba(255,255,255,0.08);
      --text: #f0f4ff;
      --text-muted: rgba(240,244,255,0.6);
      --accent: #4cc9f0;
      --accent-2: #667eea;
      --ok: #10b981;
      --warn: #fbbf24;
      --bad: #f87171;
      --novo-blue: #003580;
    }

    /* LIGHT MODE */
    [data-theme="light"] {
      --bg-primary: #f0f4f8;
      --bg-gradient: linear-gradient(135deg, #f0f4f8 0%, #e2e8f0 100%);
      --glass-bg: rgba(255,255,255,0.85);
      --glass-border: rgba(0,0,0,0.1);
      --text: #0f172a;
      --text-muted: rgba(15,23,42,0.65);
      --ok: #059669;
      --warn: #d97706;
      --bad: #dc2626;
    }
    [data-theme="light"] body { background: var(--bg-gradient); background-color: var(--bg-primary); }
    [data-theme="light"] h1, [data-theme="light"] h2, [data-theme="light"] h3,
    [data-theme="light"] p, [data-theme="light"] span, [data-theme="light"] div,
    [data-theme="light"] td, [data-theme="light"] li, [data-theme="light"] strong,
    [data-theme="light"] .kpi .value { color: var(--text); }
    [data-theme="light"] th, [data-theme="light"] .news-meta { color: var(--text-muted); }
    [data-theme="light"] .price-card { background: linear-gradient(135deg, rgba(0,53,128,0.1), rgba(76,201,240,0.05)); border-color: rgba(0,53,128,0.2); }
    [data-theme="light"] .kpi.positive .value { color: var(--ok); }
    [data-theme="light"] .kpi.negative .value { color: var(--bad); }
    [data-theme="light"] .kpi.warning .value { color: var(--warn); }
    [data-theme="light"] .verdict-text { color: inherit; }
    [data-theme="light"] .timeline::before { background: linear-gradient(180deg, var(--accent), #6366f1, var(--bad)); }

    * { box-sizing: border-box; margin: 0; padding: 0; }

    body {
      font-family: 'Inter', -apple-system, sans-serif;
      background: var(--bg-gradient);
      background-color: var(--bg-primary);
      color: var(--text);
      min-height: 100vh;
      padding: 20px;
    }

    .container { max-width: 1600px; margin: 0 auto; }

    /* Header */
    .header {
      background: var(--glass-bg);
      border: 1px solid var(--glass-border);
      border-radius: 20px;
      padding: 24px 32px;
      margin-bottom: 20px;
      backdrop-filter: blur(20px);
      display: flex;
      justify-content: space-between;
      align-items: center;
      flex-wrap: wrap;
      gap: 16px;
    }
    .header h1 { font-size: 1.8rem; font-weight: 700; }
    .header h1 span { color: var(--accent); }
    .header-meta { color: var(--text-muted); font-size: 0.9rem; }
    .live-badge {
      display: inline-flex;
      align-items: center;
      gap: 6px;
      background: rgba(16,185,129,0.15);
      color: var(--ok);
      padding: 6px 14px;
      border-radius: 20px;
      font-size: 0.8rem;
      font-weight: 600;
    }
    .live-badge::before {
      content: '';
      width: 8px;
      height: 8px;
      background: var(--ok);
      border-radius: 50%;
      animation: pulse 2s infinite;
    }
    @keyframes pulse {
      0%, 100% { opacity: 1; }
      50% { opacity: 0.4; }
    }

    /* Tabs */
    .tabs {
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
      margin-bottom: 20px;
      background: rgba(255,255,255,0.02);
      padding: 8px;
      border-radius: 16px;
      border: 1px solid var(--glass-border);
    }
    .tab-btn {
      padding: 12px 20px;
      border: none;
      background: transparent;
      color: var(--text-muted);
      cursor: pointer;
      border-radius: 12px;
      font-family: inherit;
      font-size: 0.9rem;
      font-weight: 500;
      transition: all 0.3s ease;
    }
    .tab-btn:hover { background: rgba(255,255,255,0.05); color: var(--text); }
    .tab-btn.active {
      background: linear-gradient(135deg, var(--accent), var(--accent-2));
      color: #fff;
    }
    .tab-content { display: none; }
    .tab-content.active { display: block; animation: fadeIn 0.4s ease; }
    @keyframes fadeIn {
      from { opacity: 0; transform: translateY(10px); }
      to { opacity: 1; transform: translateY(0); }
    }

    /* Cards */
    .glass {
      background: var(--glass-bg);
      border: 1px solid var(--glass-border);
      border-radius: 20px;
      backdrop-filter: blur(16px);
      padding: 24px;
      margin-bottom: 20px;
    }
    .glass h2 { font-size: 1.2rem; margin-bottom: 16px; display: flex; align-items: center; gap: 10px; }
    .glass h3 { font-size: 1rem; color: var(--text-muted); margin-bottom: 12px; }

    /* Grid */
    .grid { display: grid; gap: 20px; }
    .grid-4 { grid-template-columns: repeat(auto-fit, minmax(200px, 1fr)); }
    .grid-3 { grid-template-columns: repeat(auto-fit, minmax(280px, 1fr)); }
    .grid-2 { grid-template-columns: repeat(auto-fit, minmax(400px, 1fr)); }

    /* KPIs */
    .kpi { text-align: center; padding: 20px; }
    .kpi .value { font-size: 2.2rem; font-weight: 700; font-family: 'SF Mono', monospace; }
    .kpi .label { color: var(--text-muted); font-size: 0.75rem; text-transform: uppercase; letter-spacing: 1px; margin-top: 4px; }
    .kpi.positive .value { color: var(--ok); }
    .kpi.negative .value { color: var(--bad); }
    .kpi.warning .value { color: var(--warn); }

    /* Price Cards */
    .price-card {
      background: linear-gradient(135deg, rgba(0,53,128,0.2), rgba(76,201,240,0.1));
      border: 1px solid rgba(0,53,128,0.3);
      border-radius: 16px;
      padding: 20px;
      text-align: center;
    }
    .price-card .ticker { font-size: 0.8rem; color: var(--text-muted); margin-bottom: 4px; }
    .price-card .flag { font-size: 1.5rem; margin-bottom: 8px; }
    .price-card .price { font-size: 1.8rem; font-weight: 700; font-family: 'SF Mono', monospace; }
    .price-card .change { font-size: 0.9rem; margin-top: 8px; padding: 4px 12px; border-radius: 20px; display: inline-block; }
    .price-card .change.up { background: rgba(16,185,129,0.2); color: var(--ok); }
    .price-card .change.down { background: rgba(248,113,113,0.2); color: var(--bad); }

    /* Chart */
    .chart-container { height: 350px; position: relative; }

    /* Timeline */
    .timeline { position: relative; padding-left: 30px; }
    .timeline::before {
      content: '';
      position: absolute;
      left: 10px;
      top: 0;
      bottom: 0;
      width: 2px;
      background: linear-gradient(180deg, var(--accent), var(--accent-2), var(--bad));
    }
    .timeline-item {
      position: relative;
      margin-bottom: 20px;
      padding: 16px;
      background: var(--glass-bg);
      border: 1px solid var(--glass-border);
      border-radius: 12px;
    }
    .timeline-item::before {
      content: '';
      position: absolute;
      left: -24px;
      top: 20px;
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--accent);
      border: 2px solid var(--bg-primary);
    }
    .timeline-item.negative::before { background: var(--bad); }
    .timeline-item.positive::before { background: var(--ok); }
    .timeline-date { font-size: 0.75rem; color: var(--text-muted); margin-bottom: 4px; }
    .timeline-title { font-weight: 600; margin-bottom: 4px; }
    .timeline-impact { font-size: 0.85rem; color: var(--text-muted); }
    .timeline-price { font-size: 0.9rem; font-family: monospace; margin-top: 8px; padding: 4px 8px; background: rgba(0,0,0,0.2); border-radius: 6px; display: inline-block; }

    /* Verdict */
    .verdict-box {
      padding: 24px;
      border-radius: 16px;
      text-align: center;
    }
    .verdict-box.bullish { background: linear-gradient(135deg, rgba(16,185,129,0.15), rgba(16,185,129,0.05)); border: 1px solid rgba(16,185,129,0.3); }
    .verdict-box.bearish { background: linear-gradient(135deg, rgba(248,113,113,0.15), rgba(248,113,113,0.05)); border: 1px solid rgba(248,113,113,0.3); }
    .verdict-box.neutral { background: linear-gradient(135deg, rgba(251,191,36,0.15), rgba(251,191,36,0.05)); border: 1px solid rgba(251,191,36,0.3); }
    .verdict-label { font-size: 0.8rem; text-transform: uppercase; letter-spacing: 2px; margin-bottom: 8px; }
    .verdict-text { font-size: 1.5rem; font-weight: 700; }
    .verdict-box.bullish .verdict-text { color: var(--ok); }
    .verdict-box.bearish .verdict-text { color: var(--bad); }
    .verdict-box.neutral .verdict-text { color: var(--warn); }

    /* News */
    .news-item {
      padding: 16px;
      border-bottom: 1px solid var(--glass-border);
      display: flex;
      gap: 12px;
      align-items: flex-start;
    }
    .news-item:last-child { border-bottom: none; }
    .news-sentiment {
      width: 8px;
      height: 8px;
      border-radius: 50%;
      margin-top: 6px;
      flex-shrink: 0;
    }
    .news-sentiment.positive { background: var(--ok); }
    .news-sentiment.negative { background: var(--bad); }
    .news-sentiment.neutral { background: var(--warn); }
    .news-title { font-weight: 500; margin-bottom: 4px; }
    .news-meta { font-size: 0.8rem; color: var(--text-muted); }

    /* Table */
    table { width: 100%; border-collapse: collapse; }
    th, td { padding: 12px; text-align: left; border-bottom: 1px solid var(--glass-border); }
    th { color: var(--text-muted); font-size: 0.75rem; text-transform: uppercase; font-weight: 600; }
    td { font-size: 0.9rem; }

    /* Badges */
    .badge {
      padding: 4px 10px;
      border-radius: 20px;
      font-size: 0.75rem;
      font-weight: 600;
    }
    .badge-bullish { background: rgba(16,185,129,0.2); color: var(--ok); }
    .badge-bearish { background: rgba(248,113,113,0.2); color: var(--bad); }
    .badge-neutral { background: rgba(251,191,36,0.2); color: var(--warn); }

    /* Controls */
    .controls { display: flex; gap: 10px; }
    .ctrl-btn {
      padding: 10px 18px;
      border: 1px solid var(--glass-border);
      background: var(--glass-bg);
      color: var(--text);
      border-radius: 12px;
      cursor: pointer;
      font-family: inherit;
      font-size: 0.85rem;
      display: flex;
      align-items: center;
      gap: 8px;
      transition: all 0.3s ease;
    }
    .ctrl-btn:hover { background: rgba(76,201,240,0.15); border-color: var(--accent); }
    .ctrl-btn svg { width: 18px; height: 18px; }
    .lang-btn { padding: 6px 10px; border: none; background: transparent; color: var(--text-muted); cursor: pointer; border-radius: 6px; font-size: 0.85rem; transition: all 0.2s; }
    .lang-btn:hover { background: rgba(76,201,240,0.1); }
    .lang-btn.active { background: var(--accent); color: #000; }

    /* Print */
    @media print {
      body { background: #fff !important; color: #1e293b !important; -webkit-print-color-adjust: exact; print-color-adjust: exact; }
      .glass { background: #f8fafc !important; border-color: #e2e8f0 !important; box-shadow: none !important; }
      .tabs, .controls, .live-badge { display: none !important; }
      .tab-content { display: block !important; page-break-inside: avoid; margin-bottom: 20px; }
      .header { background: #f8fafc !important; }
      h1, h2, h3, p, span, div, td, li { color: #0f172a !important; }
      th { color: #64748b !important; }
      .kpi .value { color: #0f172a !important; }
      .kpi.positive .value { color: #059669 !important; }
      .kpi.negative .value { color: #dc2626 !important; }
      .price-card { background: #f1f5f9 !important; border: 1px solid #cbd5e1 !important; }
      .chart-container { page-break-inside: avoid; }
    }
  </style>
</head>
<body>
  <div class="container">
    <!-- Header -->
    <header class="header">
      <div>
        <h1>ğŸ“Š <span>Novo Nordisk</span> Stock Intelligence</h1>
        <p class="header-meta">AnÃ¡lise Imparcial | NVO (NYSE) â€¢ NOVO-B (CPH) â€¢ N1VO34 (B3) | Atualizado: <span id="lastUpdate">28/01/2026 14:30</span></p>
      </div>
      <div class="controls">
        <a href="index.html" class="ctrl-btn" title="Voltar ao Hub">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M19 12H5M12 19l-7-7 7-7"/></svg>
          Hub
        </a>
        <span class="live-badge">LIVE</span>
        <div class="ctrl-btn lang-toggle" style="padding:4px;gap:4px;display:flex;">
          <button class="lang-btn active" onclick="setLang('pt')">ğŸ‡§ğŸ‡·</button>
          <button class="lang-btn" onclick="setLang('en')">ğŸ‡ºğŸ‡¸</button>
        </div>
        <button class="ctrl-btn" onclick="toggleTheme()" title="Alternar tema">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" id="themeIcon"><circle cx="12" cy="12" r="5"/><path d="M12 1v2M12 21v2M4.22 4.22l1.42 1.42M18.36 18.36l1.42 1.42M1 12h2M21 12h2M4.22 19.78l1.42-1.42M18.36 5.64l1.42-1.42"/></svg>
        </button>
        <button class="ctrl-btn" onclick="window.print()">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polyline points="6 9 6 2 18 2 18 9"/><path d="M6 18H4a2 2 0 0 1-2-2v-5a2 2 0 0 1 2-2h16a2 2 0 0 1 2 2v5a2 2 0 0 1-2 2h-2"/><rect x="6" y="14" width="12" height="8"/></svg>
        </button>
      </div>
    </header>

    <!-- Tabs -->
    <div class="tabs">
      <button class="tab-btn active" data-tab="overview"><span data-pt="ğŸ“ˆ VisÃ£o Geral" data-en="ğŸ“ˆ Overview">ğŸ“ˆ VisÃ£o Geral</span></button>
      <button class="tab-btn" data-tab="timeline"><span data-pt="ğŸ“… Timeline" data-en="ğŸ“… Timeline">ğŸ“… Timeline & Eventos</span></button>
      <button class="tab-btn" data-tab="analysis"><span data-pt="ğŸ”¬ AnÃ¡lise TÃ©cnica" data-en="ğŸ”¬ Technical Analysis">ğŸ”¬ AnÃ¡lise TÃ©cnica</span></button>
      <button class="tab-btn" data-tab="predictive"><span data-pt="ğŸ”® AnÃ¡lise Preditiva" data-en="ğŸ”® Predictive Analysis">ğŸ”® AnÃ¡lise Preditiva</span></button>
      <button class="tab-btn" data-tab="news"><span data-pt="ğŸ“° NotÃ­cias" data-en="ğŸ“° News & Impact">ğŸ“° NotÃ­cias & Impacto</span></button>
      <button class="tab-btn" data-tab="verdict"><span data-pt="âš–ï¸ Veredicto" data-en="âš–ï¸ Honest Verdict">âš–ï¸ Veredicto Honesto</span></button>
      <button class="tab-btn" data-tab="pipeline"><span data-pt="ğŸ’Š Pipeline" data-en="ğŸ’Š Drug Pipeline">ğŸ’Š Pipeline & Drogas</span></button>
      <button class="tab-btn" data-tab="data"><span data-pt="ğŸ“Š Dados" data-en="ğŸ“Š Full Data">ğŸ“Š Dados Completos</span></button>
    </div>

    <!-- TAB: Overview -->
    <div id="overview" class="tab-content active">
      <!-- Price Cards -->
      <div class="grid grid-3" style="margin-bottom:20px;">
        <div class="price-card">
          <div class="flag">ğŸ‡ºğŸ‡¸</div>
          <div class="ticker">NYSE: NVO</div>
          <div class="price" id="priceUSD">$62.89</div>
          <div class="change neutral" id="changeUSD" style="background:rgba(148,163,184,0.2);color:#94a3b8;">$0.00 (0.00%)</div>
          <div style="font-size:0.7rem;color:var(--text-muted);margin-top:8px;">52W: $43.08 - $93.80</div>
        </div>
        <div class="price-card">
          <div class="flag">ğŸ‡©ğŸ‡°</div>
          <div class="ticker">CPH: NOVO-B</div>
          <div class="price" id="priceDKK">kr.385.00</div>
          <div class="change down" id="changeDKK">-kr.8.95 (-2.27%)</div>
          <div style="font-size:0.7rem;color:var(--text-muted);margin-top:8px;">52W: kr.266.90 - kr.675.20</div>
        </div>
        <div class="price-card">
          <div class="flag">ğŸ‡§ğŸ‡·</div>
          <div class="ticker">B3: N1VO34</div>
          <div class="price" id="priceBRL">R$39.99</div>
          <div class="change down" id="changeBRL">-R$1.05 (-2.56%)</div>
          <div style="font-size:0.7rem;color:var(--text-muted);margin-top:8px;">52W: R$28.54 - R$67.84</div>
        </div>
      </div>

      <!-- Key Metrics -->
      <div class="glass">
        <h2>ğŸ“Š MÃ©tricas-Chave</h2>
        <div class="grid grid-4">
          <div class="kpi">
            <div class="value">$209.6B</div>
            <div class="label">Market Cap</div>
          </div>
          <div class="kpi negative">
            <div class="value">-33%</div>
            <div class="label">YTD 2025</div>
          </div>
          <div class="kpi positive">
            <div class="value">+46%</div>
            <div class="label">Desde MÃ­n. Ago/25</div>
          </div>
          <div class="kpi">
            <div class="value">16.7x</div>
            <div class="label">P/E Forward</div>
          </div>
        </div>
      </div>

      <!-- Quick Summary -->
      <div class="grid grid-2">
        <div class="glass">
          <h2>ğŸ¯ Resumo Executivo</h2>
          <p style="color:var(--text-muted);line-height:1.7;margin-bottom:16px;">
            A Novo Nordisk estÃ¡ em <strong style="color:var(--ok);">fase de recuperaÃ§Ã£o</strong> apÃ³s uma queda brutal de 55% 
            do pico histÃ³rico ($140 em Mar/2024) atÃ© a mÃ­nima de $45 em Ago/2025. O catalisador principal foi a 
            <strong>aprovaÃ§Ã£o da pÃ­lula Wegovy pela FDA</strong> (Dez/2025), que resolve o gargalo de produÃ§Ã£o.
          </p>
          <div class="verdict-box bullish" style="margin-top:16px;">
            <div class="verdict-label">TendÃªncia Atual</div>
            <div class="verdict-text">ğŸ“ˆ RECUPERAÃ‡ÃƒO</div>
          </div>
        </div>
        <div class="glass">
          <h2>âš¡ Eventos Recentes</h2>
          <div class="news-item">
            <div class="news-sentiment positive"></div>
            <div>
              <div class="news-title">Wegovy Pill: 18K prescriÃ§Ãµes na 1Âª semana</div>
              <div class="news-meta">23/Jan/2026 â€¢ Demanda forte confirma tese</div>
            </div>
          </div>
          <div class="news-item">
            <div class="news-sentiment positive"></div>
            <div>
              <div class="news-title">Q4 2025: Analistas esperam beat</div>
              <div class="news-meta">26/Jan/2026 â€¢ Earnings preview positivo</div>
            </div>
          </div>
          <div class="news-item">
            <div class="news-sentiment negative"></div>
            <div>
              <div class="news-title">GenÃ©ricos na Ãndia: Sun Pharma e Dr. Reddy's</div>
              <div class="news-meta">21-23/Jan/2026 â€¢ Risco de longo prazo</div>
            </div>
          </div>
        </div>
      </div>

      <!-- Chart -->
      <div class="glass">
        <h2>ğŸ“ˆ PreÃ§o NVO (12 meses)</h2>
        <div class="chart-container">
          <canvas id="priceChart"></canvas>
        </div>
      </div>

      <!-- 3 Stocks Comparison -->
      <div class="glass">
        <h2>ğŸŒ Comparativo: 3 Bolsas (normalizado %)</h2>
        <div class="chart-container">
          <canvas id="threeStocksChart"></canvas>
        </div>
        <p style="color:var(--text-muted);font-size:0.8rem;margin-top:12px;text-align:center;">Retornos normalizados desde Jan/2025 - Fonte: Yahoo Finance, Google Finance, B3</p>
      </div>
    </div>
    <div id="timeline" class="tab-content">
      <div class="glass">
        <h2>ğŸ“… Timeline: Eventos que Moveram o PreÃ§o</h2>
        <p style="color:var(--text-muted);margin-bottom:20px;">CorrelaÃ§Ã£o direta entre notÃ­cias e movimentos de preÃ§o da NVO</p>
        
        <div class="timeline">
          <div class="timeline-item positive">
            <div class="timeline-date">23 Jan 2026</div>
            <div class="timeline-title">ğŸ“ˆ Wegovy Pill: 18.000+ prescriÃ§Ãµes na primeira semana</div>
            <div class="timeline-impact">Demanda explosiva confirma tese de escalabilidade da pÃ­lula</div>
            <div class="timeline-price">$62.26 â†’ $63.60 (+2.15%)</div>
          </div>
          
          <div class="timeline-item positive">
            <div class="timeline-date">22 Dez 2025</div>
            <div class="timeline-title">ğŸ‰ FDA Aprova PÃ­lula Wegovy (Oral Semaglutide)</div>
            <div class="timeline-impact">GAME CHANGER - Resolve gargalo de produÃ§Ã£o, aumenta acessibilidade</div>
            <div class="timeline-price">$48.10 â†’ $51.61 (+7.3%)</div>
          </div>

          <div class="timeline-item negative">
            <div class="timeline-date">24 Nov 2025</div>
            <div class="timeline-title">âš ï¸ Estudo Alzheimer Interrompido</div>
            <div class="timeline-impact">Ozempic nÃ£o mostrou eficÃ¡cia em estudo de Alzheimer</div>
            <div class="timeline-price">$47.63 â†’ $44.97 (-5.6%)</div>
          </div>

          <div class="timeline-item">
            <div class="timeline-date">05 Nov 2025</div>
            <div class="timeline-title">ğŸ“Š Q3 2025 Earnings Call</div>
            <div class="timeline-impact">Resultados mistos, guidance mantido</div>
            <div class="timeline-price">$48.46 â†’ $46.51 (-4%)</div>
          </div>

          <div class="timeline-item negative">
            <div class="timeline-date">Set 2025</div>
            <div class="timeline-title">ğŸ”» ReestruturaÃ§Ã£o: Corte de 9.000-10.000 funcionÃ¡rios</div>
            <div class="timeline-impact">Medida de reduÃ§Ã£o de custos apÃ³s queda de market cap</div>
            <div class="timeline-price">~$55 (estabilizaÃ§Ã£o)</div>
          </div>

          <div class="timeline-item negative">
            <div class="timeline-date">29 Jul 2025</div>
            <div class="timeline-title">ğŸ’¥ CRASH: Resultados CagriSema Decepcionam</div>
            <div class="timeline-impact">Perda de peso de 22.7% vs esperado 25%+, mercado perde confianÃ§a</div>
            <div class="timeline-price">$71.70 â†’ $53.94 (-24.8% em 1 dia!)</div>
          </div>

          <div class="timeline-item negative">
            <div class="timeline-date">Abr 2025</div>
            <div class="timeline-title">ğŸ“‰ Tarifas e Medo de RegulaÃ§Ã£o</div>
            <div class="timeline-impact">PreocupaÃ§Ãµes com tarifas de importaÃ§Ã£o nos EUA</div>
            <div class="timeline-price">$90 â†’ $62 (-31%)</div>
          </div>

          <div class="timeline-item positive">
            <div class="timeline-date">Mar 2024</div>
            <div class="timeline-title">ğŸ† PICO HISTÃ“RICO: Maior empresa da Europa</div>
            <div class="timeline-impact">Ozempic/Wegovy dominando, market cap > $600B</div>
            <div class="timeline-price">$140+ (ATH)</div>
          </div>
        </div>
      </div>

      <!-- Pattern Analysis -->
      <div class="glass">
        <h2>ğŸ” PadrÃ£o Identificado: O que Faz a AÃ§Ã£o Subir ou Cair?</h2>
        <div class="grid grid-2">
          <div style="padding:16px;background:rgba(16,185,129,0.1);border-radius:12px;border-left:4px solid var(--ok);">
            <h3 style="color:var(--ok);margin-bottom:12px;">ğŸ“ˆ CATALISADORES DE ALTA</h3>
            <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
              <li><strong>AprovaÃ§Ãµes FDA/EMA</strong> - Sempre gera rally (+5-10%)</li>
              <li><strong>Resultados de estudos clÃ­nicos positivos</strong></li>
              <li><strong>Earnings beats</strong> - Especialmente guidance elevado</li>
              <li><strong>ExpansÃ£o de capacidade produtiva</strong></li>
              <li><strong>PÃ­lula oral</strong> - Resolve gargalo de supply</li>
            </ul>
          </div>
          <div style="padding:16px;background:rgba(248,113,113,0.1);border-radius:12px;border-left:4px solid var(--bad);">
            <h3 style="color:var(--bad);margin-bottom:12px;">ğŸ“‰ CATALISADORES DE BAIXA</h3>
            <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
              <li><strong>Estudos clÃ­nicos decepcionantes</strong> - CagriSema foi devastador</li>
              <li><strong>CompetiÃ§Ã£o Eli Lilly</strong> - Zepbound ganhando share</li>
              <li><strong>GenÃ©ricos aprovados</strong> - Ãndia jÃ¡ liberou (Sun, Dr. Reddy's)</li>
              <li><strong>RegulaÃ§Ã£o/Tarifas</strong> - Medo de pricing pressure</li>
              <li><strong>Processos judiciais</strong> - Ex: acordo Teva (Victoza)</li>
            </ul>
          </div>
        </div>
      </div>
    </div>
    <div id="analysis" class="tab-content">
      <div class="grid grid-2">
        <!-- Technical Indicators -->
        <div class="glass">
          <h2>ğŸ“Š Indicadores TÃ©cnicos</h2>
          <table>
            <tr><th>Indicador</th><th>Valor</th><th>Sinal</th></tr>
            <tr><td>SMA 20 dias</td><td>$60.12</td><td><span class="badge badge-bullish">Acima</span></td></tr>
            <tr><td>SMA 50 dias</td><td>$51.78</td><td><span class="badge badge-bullish">+20% acima</span></td></tr>
            <tr><td>SMA 200 dias</td><td>$58.93</td><td><span class="badge badge-bullish">+5.7% acima</span></td></tr>
            <tr><td>RSI (14)</td><td>62</td><td><span class="badge badge-neutral">Neutro</span></td></tr>
            <tr><td>MACD</td><td>Positivo</td><td><span class="badge badge-bullish">Bullish</span></td></tr>
            <tr><td>Beta (24M)</td><td>1.36</td><td><span class="badge badge-neutral">VolÃ¡til</span></td></tr>
          </table>
        </div>

        <!-- Valuation -->
        <div class="glass">
          <h2>ğŸ’° Valuation: NVO vs LLY (4 Fev 2026)</h2>
          <table>
            <tr><th>MÃ©trica</th><th>NVO</th><th>LLY</th><th>Vencedor</th></tr>
            <tr><td>P/E Forward</td><td style="color:var(--ok);">18x</td><td>32.5x</td><td>ğŸ† NVO</td></tr>
            <tr><td>EPS Est. Q4</td><td>$0.89-0.90</td><td style="color:var(--ok);">$7.11-7.48</td><td>ğŸ† LLY</td></tr>
            <tr><td>Receita Est. Q4</td><td>$12B</td><td style="color:var(--ok);">$17.85B</td><td>ğŸ† LLY</td></tr>
            <tr><td>Crescimento YoY</td><td style="color:var(--warn);">EstÃ¡vel</td><td style="color:var(--ok);">+32%</td><td>ğŸ† LLY</td></tr>
            <tr><td>Profit Margin</td><td style="color:var(--ok);">32.9%</td><td>18%</td><td>ğŸ† NVO</td></tr>
            <tr><td>Upside Potencial</td><td style="color:var(--ok);">+53%</td><td>+31%</td><td>ğŸ† NVO</td></tr>
          </table>
          <div class="grid grid-2" style="margin-top:16px;">
            <div style="padding:12px;background:rgba(0,53,128,0.15);border-radius:8px;">
              <div style="font-weight:600;color:var(--accent);margin-bottom:4px;">ğŸ‡©ğŸ‡° NVO = "OpÃ§Ã£o de Valor"</div>
              <div style="font-size:0.85rem;color:var(--text-muted);">MÃºltiplo baixo + maior margem</div>
            </div>
            <div style="padding:12px;background:rgba(248,113,113,0.1);border-radius:8px;">
              <div style="font-weight:600;color:var(--bad);margin-bottom:4px;">ğŸ‡ºğŸ‡¸ LLY = "OpÃ§Ã£o de Crescimento"</div>
              <div style="font-size:0.85rem;color:var(--text-muted);">MÃºltiplo premium + alto crescimento</div>
            </div>
          </div>
        </div>
      </div>

      <!-- Analyst Ratings -->
      <div class="glass">
        <h2>ğŸ¯ Ratings de Analistas (Jan 2026)</h2>
        <div class="grid grid-4">
          <div class="verdict-box bullish">
            <div class="verdict-label">SA Analysts</div>
            <div class="verdict-text">BUY</div>
          </div>
          <div class="verdict-box bullish">
            <div class="verdict-label">Wall Street</div>
            <div class="verdict-text">BUY</div>
          </div>
          <div class="verdict-box neutral">
            <div class="verdict-label">Quant Rating</div>
            <div class="verdict-text">HOLD</div>
          </div>
          <div class="verdict-box neutral">
            <div class="verdict-label">Morgan Stanley</div>
            <div class="verdict-text">UNDERWEIGHT</div>
          </div>
        </div>
        <div style="margin-top:20px;">
          <h3>ğŸ“Š Estimativas de PreÃ§o-Alvo:</h3>
          <div class="grid grid-3" style="margin-top:12px;">
            <div style="padding:12px;background:rgba(248,113,113,0.1);border-radius:8px;text-align:center;">
              <div style="font-size:0.75rem;color:var(--text-muted);">BMO Capital</div>
              <div style="font-size:1.5rem;font-weight:700;color:var(--bad);">$46</div>
              <div style="font-size:0.7rem;color:var(--text-muted);">(-27% atual)</div>
            </div>
            <div style="padding:12px;background:rgba(76,201,240,0.1);border-radius:8px;text-align:center;">
              <div style="font-size:0.75rem;color:var(--text-muted);">Morningstar FVE</div>
              <div style="font-size:1.5rem;font-weight:700;color:var(--accent);">DKK 423</div>
              <div style="font-size:0.7rem;color:var(--text-muted);">(~$60 USD)</div>
            </div>
            <div style="padding:12px;background:rgba(16,185,129,0.1);border-radius:8px;text-align:center;">
              <div style="font-size:0.75rem;color:var(--text-muted);">WSJ Consenso</div>
              <div style="font-size:1.5rem;font-weight:700;color:var(--ok);">$96</div>
              <div style="font-size:0.7rem;color:var(--text-muted);">(+53% upside)</div>
            </div>
          </div>
        </div>
        <div style="margin-top:16px;">
          <h3>Factor Grades:</h3>
          <div style="display:flex;gap:12px;flex-wrap:wrap;margin-top:12px;">
            <span class="badge" style="background:rgba(248,113,113,0.2);color:var(--bad);">Valuation: D+</span>
            <span class="badge badge-bullish">Growth: B</span>
            <span class="badge badge-bullish">Profitability: A+</span>
            <span class="badge badge-neutral">Momentum: C+</span>
            <span class="badge badge-bullish">EPS Revisions: B-</span>
          </div>
        </div>
      </div>

      <!-- Price Targets -->
      <div class="glass">
        <h2>ğŸ¯ Price Targets</h2>
        <div class="grid grid-4">
          <div class="kpi">
            <div class="value">$43.08</div>
            <div class="label">52-Week Low</div>
          </div>
          <div class="kpi">
            <div class="value" style="color:var(--accent);">$62.89</div>
            <div class="label">PreÃ§o Atual</div>
          </div>
          <div class="kpi">
            <div class="value">$93.80</div>
            <div class="label">52-Week High</div>
          </div>
          <div class="kpi positive">
            <div class="value">+49%</div>
            <div class="label">Upside ao High</div>
          </div>
        </div>
      </div>

      <!-- Earnings Calendar -->
      <div class="glass" style="border-left:4px solid var(--warn);">
        <h2>ğŸ“… Earnings Calendar - PRÃ“XIMO RESULTADO (CRÃTICO!)</h2>
        <div class="grid grid-2">
          <div style="padding:20px;background:linear-gradient(135deg, rgba(251,191,36,0.15), rgba(251,191,36,0.05));border-radius:16px;">
            <div style="color:var(--warn);font-size:0.8rem;text-transform:uppercase;letter-spacing:1px;margin-bottom:8px;">ğŸ“¢ Q4 2025 + FY2025 Results</div>
            <div style="font-size:2rem;font-weight:700;">4 Fev 2026</div>
            <div style="color:var(--text-muted);margin-top:4px;">Antes abertura Copenhagen (13:00 CET)</div>
            <div style="margin-top:12px;padding:12px;background:rgba(0,0,0,0.2);border-radius:8px;">
              <strong>â±ï¸ Faltam 7 dias</strong>
              <div style="font-size:0.8rem;color:var(--text-muted);margin-top:4px;">TeleconferÃªncia: 09:00 BRT</div>
            </div>
          </div>
          <div>
            <table>
              <tr><th colspan="2">ğŸ“Š Estimativas Q4 2025 (Consenso)</th></tr>
              <tr><td style="color:var(--text-muted);">EPS Estimado</td><td style="font-weight:600;">$0.89 - $0.90</td></tr>
              <tr><td style="color:var(--text-muted);">Receita Estimada</td><td style="font-weight:600;">$11.96B - $12.13B</td></tr>
              <tr><td style="color:var(--text-muted);">Guidance 2026</td><td style="font-weight:600;">+5% a +8.5%</td></tr>
              <tr><td style="color:var(--text-muted);">Fonte</td><td>Zacks, Morningstar</td></tr>
            </table>
          </div>
        </div>
        
        <!-- What to Watch -->
        <div style="margin-top:20px;padding:16px;background:rgba(76,201,240,0.1);border-radius:12px;">
          <strong style="color:var(--accent);">ğŸ” O QUE O MERCADO QUER SABER:</strong>
          <div class="grid grid-2" style="margin-top:12px;gap:16px;">
            <div>
              <div style="font-weight:600;color:var(--ok);margin-bottom:8px;">ğŸ“ˆ Catalisadores Positivos</div>
              <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;font-size:0.9rem;">
                <li><strong>Wegovy Pill:</strong> Dados de 18.410+ prescriÃ§Ãµes na 1Âª semana</li>
                <li><strong>Guidance 2026:</strong> Primeiro forecast oficial do ano</li>
                <li><strong>CagriSema:</strong> AtualizaÃ§Ãµes do pedido FDA (submetido Dez/25)</li>
                <li><strong>Amycretin:</strong> InÃ­cio da Fase III anunciado</li>
              </ul>
            </div>
            <div>
              <div style="font-weight:600;color:var(--bad);margin-bottom:8px;">âš ï¸ Riscos a Monitorar</div>
              <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;font-size:0.9rem;">
                <li><strong>Custos ReestruturaÃ§Ã£o:</strong> DKK 8B impactando margem</li>
                <li><strong>PreÃ§os TrumpRx:</strong> US$245-350 (70% desconto)</li>
                <li><strong>Patentes:</strong> Vencimento Brasil, China, CanadÃ¡</li>
                <li><strong>CompetiÃ§Ã£o LLY:</strong> Zepbound ganhando share</li>
              </ul>
            </div>
          </div>
        </div>

        <div style="margin-top:16px;padding:16px;background:rgba(16,185,129,0.1);border-radius:12px;">
          <strong style="color:var(--ok);">ğŸ“Š Ãšltimo Resultado (Q3 - 5 Nov 2025):</strong>
          <div style="display:flex;gap:24px;flex-wrap:wrap;margin-top:12px;">
            <div><span style="color:var(--text-muted);">EPS:</span> <span style="color:var(--ok);">$0.69 (Beat by $0.04)</span></div>
            <div><span style="color:var(--text-muted);">Revenue:</span> <span style="color:var(--bad);">$11.54B (Miss by $323M)</span></div>
          </div>
        </div>
      </div>

      <!-- Institutional Holders -->
      <div class="glass">
        <h2>ğŸ›ï¸ Maiores Investidores Institucionais</h2>
        <div style="margin-bottom:16px;padding:12px;background:rgba(76,201,240,0.1);border-radius:8px;">
          <div style="display:flex;justify-content:space-between;flex-wrap:wrap;gap:12px;">
            <div><span style="color:var(--text-muted);">Insiders:</span> <strong>0.00%</strong></div>
            <div><span style="color:var(--text-muted);">Institucionais:</span> <strong>9.12%</strong></div>
            <div><span style="color:var(--text-muted);">NÂº InstituiÃ§Ãµes:</span> <strong>1,652</strong></div>
          </div>
        </div>
        <table>
          <tr><th>InstituiÃ§Ã£o</th><th>AÃ§Ãµes (M)</th><th>% Float</th><th>Valor (USD)</th></tr>
          <tr><td>Capital International Investors</td><td>17.71M</td><td>0.52%</td><td>$1.13B</td></tr>
          <tr><td>Loomis Sayles & Co</td><td>16.17M</td><td>0.48%</td><td>$1.03B</td></tr>
          <tr><td>FMR LLC (Fidelity)</td><td>14.08M</td><td>0.42%</td><td>$895M</td></tr>
          <tr><td>Franklin Resources</td><td>13.98M</td><td>0.41%</td><td>$889M</td></tr>
          <tr><td>Bank of America</td><td>13.40M</td><td>0.40%</td><td>$852M</td></tr>
          <tr><td>Morgan Stanley</td><td>12.41M</td><td>0.37%</td><td>$789M</td></tr>
          <tr><td>JPMorgan Chase</td><td>10.82M</td><td>0.32%</td><td>$688M</td></tr>
          <tr><td>Fisher Asset Management</td><td>10.32M</td><td>0.30%</td><td>$656M</td></tr>
        </table>
        <p style="color:var(--text-muted);margin-top:12px;font-size:0.85rem;">
          ğŸ“ <strong>Nota:</strong> Baixa participaÃ§Ã£o institucional (9%) Ã© tÃ­pico de ADRs - aÃ§Ãµes sÃ£o primariamente negociadas na bolsa de Copenhagen (NOVO-B).
        </p>
      </div>

      <!-- Risk Metrics -->
      <div class="glass">
        <h2>âš ï¸ MÃ©tricas de Risco</h2>
        <div class="grid grid-4">
          <div class="kpi warning">
            <div class="value">1.36</div>
            <div class="label">Beta (24M)</div>
          </div>
          <div class="kpi negative">
            <div class="value">-55%</div>
            <div class="label">Max Drawdown (ATH)</div>
          </div>
          <div class="kpi">
            <div class="value">32%</div>
            <div class="label">Volatilidade Anual</div>
          </div>
          <div class="kpi positive">
            <div class="value">0.42</div>
            <div class="label">Sharpe Ratio</div>
          </div>
        </div>
        <div class="grid grid-2" style="margin-top:20px;">
          <div style="padding:16px;background:rgba(248,113,113,0.1);border-radius:12px;">
            <h3 style="color:var(--bad);margin-bottom:12px;">ğŸ”´ Fatores de Risco</h3>
            <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
              <li><strong>Beta > 1</strong> - Mais volÃ¡til que o mercado</li>
              <li><strong>ConcentraÃ§Ã£o</strong> - 80%+ receita em GLP-1</li>
              <li><strong>Drawdown severo</strong> - Caiu 55% do pico</li>
              <li><strong>GenÃ©ricos</strong> - PressÃ£o de preÃ§o iminente</li>
            </ul>
          </div>
          <div style="padding:16px;background:rgba(16,185,129,0.1);border-radius:12px;">
            <h3 style="color:var(--ok);margin-bottom:12px;">ğŸŸ¢ Fatores de ProteÃ§Ã£o</h3>
            <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
              <li><strong>Dividendos</strong> - Yield 2.77% como buffer</li>
              <li><strong>Profitabilidade A+</strong> - Margens de 33%</li>
              <li><strong>Balance sheet</strong> - Caixa sÃ³lido vs dÃ­vida</li>
              <li><strong>Pipeline</strong> - MÃºltiplas aprovaÃ§Ãµes em andamento</li>
            </ul>
          </div>
        </div>
      </div>

      <!-- Patent Risks - NEW SECTION -->
      <div class="glass" style="border-left:4px solid var(--bad);">
        <h2>âš ï¸ ALERTA: Riscos de Patentes 2026</h2>
        <p style="color:var(--text-muted);margin-bottom:16px;">Vencimento de patentes da semaglutida pode abrir espaÃ§o para genÃ©ricos em mercados-chave.</p>
        <table>
          <tr><th>PaÃ­s</th><th>Status Patente</th><th>Impacto</th><th>Risco</th></tr>
          <tr style="background:rgba(248,113,113,0.1);">
            <td>ğŸ‡¨ğŸ‡¦ CanadÃ¡</td>
            <td style="color:var(--bad);">ERRO ADMINISTRATIVO</td>
            <td>Pagamento de taxa atrasado</td>
            <td><span class="badge badge-bearish">CRÃTICO</span></td>
          </tr>
          <tr>
            <td>ğŸ‡§ğŸ‡· Brasil</td>
            <td style="color:var(--warn);">Vence 2026</td>
            <td>GenÃ©ricos podem entrar</td>
            <td><span class="badge badge-neutral">MÃ‰DIO</span></td>
          </tr>
          <tr>
            <td>ğŸ‡¨ğŸ‡³ China</td>
            <td style="color:var(--warn);">Vence 2026</td>
            <td>Mercado grande em risco</td>
            <td><span class="badge badge-neutral">MÃ‰DIO</span></td>
          </tr>
          <tr>
            <td>ğŸ‡®ğŸ‡³ Ãndia</td>
            <td style="color:var(--bad);">JÃ APROVADOS</td>
            <td>Sun Pharma, Dr. Reddy's</td>
            <td><span class="badge badge-bearish">ATIVO</span></td>
          </tr>
          <tr style="background:rgba(16,185,129,0.1);">
            <td>ğŸ‡ºğŸ‡¸ EUA</td>
            <td style="color:var(--ok);">Protegido atÃ© 2032+</td>
            <td>Mercado principal seguro</td>
            <td><span class="badge badge-bullish">BAIXO</span></td>
          </tr>
        </table>
        <div style="margin-top:16px;padding:12px;background:rgba(251,191,36,0.1);border-radius:8px;">
          <strong style="color:var(--warn);">ğŸ“Œ Caso CanadÃ¡:</strong>
          <span style="color:var(--text-muted);font-size:0.9rem;"> Erro de ~R$1.400 em taxas pode custar bilhÃµes em receita perdida (Science Magazine).</span>
        </div>
      </div>
    </div>
    <!-- TAB: Predictive Analysis -->
    <div id="predictive" class="tab-content">
      <div class="glass" style="border-left:4px solid var(--accent);">
        <h2>ğŸ”® AnÃ¡lise Preditiva - TendÃªncias e ProjeÃ§Ãµes</h2>
        <p style="color:var(--text-muted);margin-bottom:20px;">ProjeÃ§Ãµes baseadas em anÃ¡lise tÃ©cnica, fundamentalista e sentimento de mercado. <strong>NÃ£o Ã© recomendaÃ§Ã£o de investimento.</strong></p>
      </div>

      <!-- Price Projections -->
      <div class="glass">
        <h2>ğŸ“Š ProjeÃ§Ã£o de PreÃ§o - CenÃ¡rios</h2>
        <div class="chart-container">
          <canvas id="predictiveChart"></canvas>
        </div>
      </div>

      <!-- Short Term (7-30 days) -->
      <div class="grid grid-2">
        <div class="glass" style="border-left:4px solid var(--accent);">
          <h2>ğŸ“… Curto Prazo (7-30 dias)</h2>
          <div class="grid grid-3" style="margin-bottom:16px;">
            <div class="kpi">
              <div class="value" style="color:var(--bad);">$58</div>
              <div class="label">Suporte</div>
            </div>
            <div class="kpi">
              <div class="value" style="color:var(--accent);">$63</div>
              <div class="label">Atual</div>
            </div>
            <div class="kpi">
              <div class="value" style="color:var(--ok);">$72</div>
              <div class="label">ResistÃªncia</div>
            </div>
          </div>
          <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
            <li><strong>Catalisador:</strong> Q4 Earnings (4 Feb) - Pode mover Â±10%</li>
            <li><strong>RSI 62:</strong> Neutro com viÃ©s altista</li>
            <li><strong>Volume:</strong> Acima da mÃ©dia - momentum positivo</li>
            <li><strong>TendÃªncia:</strong> SMA20 > SMA50 = Bullish crossover</li>
          </ul>
          <div class="verdict-box bullish" style="margin-top:16px;">
            <div class="verdict-label">PrevisÃ£o 30 dias</div>
            <div class="verdict-text">$65-72 (OTIMISTA)</div>
          </div>
        </div>

        <div class="glass" style="border-left:4px solid var(--warn);">
          <h2>ğŸ“† MÃ©dio Prazo (1-3 meses)</h2>
          <div class="grid grid-3" style="margin-bottom:16px;">
            <div class="kpi">
              <div class="value" style="color:var(--bad);">$52</div>
              <div class="label">Pior Caso</div>
            </div>
            <div class="kpi">
              <div class="value" style="color:var(--warn);">$68</div>
              <div class="label">Base</div>
            </div>
            <div class="kpi">
              <div class="value" style="color:var(--ok);">$85</div>
              <div class="label">Melhor Caso</div>
            </div>
          </div>
          <ul style="color:var(--text-muted);line-height:1.8;padding-left:20px;">
            <li><strong>Q4 + Q1 Guidance:</strong> Define tendÃªncia do trimestre</li>
            <li><strong>PÃ­lula Wegovy:</strong> Dados de adoÃ§Ã£o = driver principal</li>
            <li><strong>CompetiÃ§Ã£o LLY:</strong> Market share em foco</li>
            <li><strong>GenÃ©ricos:</strong> Impacto ainda limitado</li>
          </ul>
          <div class="verdict-box neutral" style="margin-top:16px;">
            <div class="verdict-label">PrevisÃ£o 3 meses</div>
            <div class="verdict-text">$65-78 (NEUTRO/OTIMISTA)</div>
          </div>
        </div>
      </div>

      <!-- Long Term (6-12 months) -->
      <div class="glass" style="border-left:4px solid var(--ok);">
        <h2>ğŸ“ˆ Longo Prazo (6-12 meses) - Price Targets de Analistas</h2>
        <div class="grid grid-4">
          <div class="kpi">
            <div class="value" style="color:var(--bad);">$46</div>
            <div class="label">Bear (BMO Capital)</div>
          </div>
          <div class="kpi">
            <div class="value" style="color:var(--warn);">$60</div>
            <div class="label">Fair Value (Morningstar)</div>
          </div>
          <div class="kpi">
            <div class="value" style="color:var(--ok);">$96</div>
            <div class="label">Consenso WSJ</div>
          </div>
          <div class="kpi positive">
            <div class="value">$120+</div>
            <div class="label">Bull Case (CagriSema)</div>
          </div>
        </div>
        <div style="margin-top:20px;padding:16px;background:rgba(76,201,240,0.1);border-radius:12px;">
          <strong style="color:var(--accent);">ğŸ¯ Consenso Wall Street Journal: $96 (+53% upside)</strong>
          <p style="color:var(--text-muted);margin-top:8px;font-size:0.9rem;">
            PreÃ§o atual ~$62 implica P/E de apenas 18x vs LLY 32.5x. Se NVO atingir P/E de 25x com EPS $4.20 em 2026 = $105.
          </p>
        </div>
        <table class="data-table" style="margin-top:16px;">
          <thead><tr><th>Analista</th><th>Target</th><th>Upside</th><th>Rating</th></tr></thead>
          <tbody>
            <tr><td>WSJ Consenso (20 analysts)</td><td style="color:var(--ok);font-weight:700;">$96</td><td>+53%</td><td>ğŸŸ¢ Buy</td></tr>
            <tr><td>Morningstar FVE</td><td style="color:var(--warn);">$60</td><td>-3%</td><td>ğŸŸ¡ 3 Stars</td></tr>
            <tr><td>Morgan Stanley</td><td style="color:var(--warn);">N/A</td><td>-</td><td>ğŸ”´ Underweight</td></tr>
            <tr><td>BMO Capital Markets</td><td style="color:var(--bad);">$46</td><td>-26%</td><td>ğŸ”´ Underperform</td></tr>
          </tbody>
        </table>
      </div>

      <!-- Trend Indicators -->
      <div class="glass">
        <h2>ğŸ“Š Indicadores de TendÃªncia</h2>
        <div class="grid grid-2">
          <div>
            <h3 style="margin-bottom:12px;">Momentum Score</h3>
            <div style="height:20px;background:rgba(255,255,255,0.1);border-radius:10px;overflow:hidden;margin-bottom:8px;">
              <div style="height:100%;width:68%;background:linear-gradient(90deg,var(--ok),var(--accent));border-radius:10px;"></div>
            </div>
            <div style="display:flex;justify-content:space-between;font-size:0.8rem;color:var(--text-muted);">
              <span>Bearish</span><span><strong style="color:var(--ok);">68/100 - Bullish</strong></span><span>Bullish</span>
            </div>
          </div>
          <div>
            <h3 style="margin-bottom:12px;">Volatility Index</h3>
            <div style="height:20px;background:rgba(255,255,255,0.1);border-radius:10px;overflow:hidden;margin-bottom:8px;">
              <div style="height:100%;width:45%;background:linear-gradient(90deg,var(--ok),var(--warn));border-radius:10px;"></div>
            </div>
            <div style="display:flex;justify-content:space-between;font-size:0.8rem;color:var(--text-muted);">
              <span>Low</span><span><strong style="color:var(--warn);">45/100 - Moderate</strong></span><span>High</span>
            </div>
          </div>
        </div>
      </div>

      <!-- Key Dates -->
      <div class="glass">
        <h2>ğŸ“… Datas-Chave para Monitorar</h2>
        <div class="grid grid-3">
          <div style="padding:16px;background:linear-gradient(135deg, rgba(251,191,36,0.15), rgba(251,191,36,0.05));border-radius:12px;text-align:center;">
            <div style="font-size:2rem;margin-bottom:4px;">ğŸ“Š</div>
            <div style="font-weight:700;">4 Fev 2026</div>
            <div style="color:var(--text-muted);font-size:0.85rem;">Q4 Earnings</div>
            <div style="color:var(--warn);font-size:0.75rem;margin-top:4px;">âš¡ Alta Volatilidade Esperada</div>
          </div>
          <div style="padding:16px;background:linear-gradient(135deg, rgba(76,201,240,0.15), rgba(76,201,240,0.05));border-radius:12px;text-align:center;">
            <div style="font-size:2rem;margin-bottom:4px;">ğŸ’Š</div>
            <div style="font-weight:700;">Mar-Abr 2026</div>
            <div style="color:var(--text-muted);font-size:0.85rem;">Dados PÃ­lula 90 dias</div>
            <div style="color:var(--accent);font-size:0.75rem;margin-top:4px;">ğŸ“ˆ Potencial Catalisador</div>
          </div>
          <div style="padding:16px;background:linear-gradient(135deg, rgba(16,185,129,0.15), rgba(16,185,129,0.05));border-radius:12px;text-align:center;">
            <div style="font-size:2rem;margin-bottom:4px;">ğŸ”¬</div>
            <div style="font-weight:700;">Q2 2026</div>
            <div style="color:var(--text-muted);font-size:0.85rem;">CagriSema FDA Review</div>
            <div style="color:var(--ok);font-size:0.75rem;margin-top:4px;">ğŸ¯ Blockbuster 25% Weight Loss</div>
          </div>
        </div>
      </div>

      <!-- 2026 Outlook Analysis -->
      <div class="glass" style="border:2px solid var(--accent);">
        <h2>ğŸ”® AnÃ¡lise de Perspectivas 2026 - Minha VisÃ£o</h2>
        
        <div style="padding:16px;background:rgba(76,201,240,0.1);border-radius:12px;margin-bottom:20px;">
          <h3 style="color:var(--accent);margin-bottom:12px;">ğŸ“Š Por que NVO estÃ¡ subvalorizada?</h3>
          <div class="grid grid-2" style="gap:16px;">
            <div>
              <p style="color:var(--text-muted);line-height:1.7;">
                <strong>P/E de apenas 18x</strong> vs Eli Lilly 32.5x. Isso implica que o mercado precifica:
              </p>
              <ul style="color:var(--text-muted);padding-left:20px;margin-top:8px;line-height:1.8;">
                <li>âŒ Perda de market share para LLY</li>
                <li>âŒ GenÃ©ricos destruindo margens</li>
                <li>âŒ Pipeline fracassando</li>
              </ul>
            </div>
            <div>
              <p style="color:var(--text-muted);line-height:1.7;">
                <strong>Realidade:</strong>
              </p>
              <ul style="color:var(--text-muted);padding-left:20px;margin-top:8px;line-height:1.8;">
                <li>âœ… Wegovy Pill: 18,410 Rx na semana 1</li>
                <li>âœ… CagriSema: 25% weight loss (superior)</li>
                <li>âœ… Guidance +5-8.5% crescimento 2026</li>
              </ul>
            </div>
          </div>
        </div>

        <div class="grid grid-3" style="gap:16px;margin-bottom:20px;">
          <div style="padding:16px;background:rgba(239,68,68,0.1);border-radius:12px;border-left:4px solid var(--bad);">
            <h4 style="color:var(--bad);margin-bottom:8px;">ğŸ» CenÃ¡rio Bear ($46-55)</h4>
            <ul style="color:var(--text-muted);font-size:0.85rem;line-height:1.6;padding-left:16px;">
              <li>Q4 abaixo de $11.5B receita</li>
              <li>Wegovy pill falha em escalar</li>
              <li>LLY domina com Zepbound</li>
              <li>CagriSema atrasa aprovaÃ§Ã£o</li>
            </ul>
            <div style="margin-top:8px;color:var(--bad);font-weight:700;">Probabilidade: 20%</div>
          </div>
          <div style="padding:16px;background:rgba(251,191,36,0.1);border-radius:12px;border-left:4px solid var(--warn);">
            <h4 style="color:var(--warn);margin-bottom:8px;">ğŸ“Š CenÃ¡rio Base ($70-85)</h4>
            <ul style="color:var(--text-muted);font-size:0.85rem;line-height:1.6;padding-left:16px;">
              <li>Q4 em linha com $12B</li>
              <li>Guidance mantido +5-8%</li>
              <li>PÃ­lula ganha traÃ§Ã£o gradual</li>
              <li>CagriSema aprovado H2 2026</li>
            </ul>
            <div style="margin-top:8px;color:var(--warn);font-weight:700;">Probabilidade: 50%</div>
          </div>
          <div style="padding:16px;background:rgba(16,185,129,0.1);border-radius:12px;border-left:4px solid var(--ok);">
            <h4 style="color:var(--ok);margin-bottom:8px;">ğŸš€ CenÃ¡rio Bull ($96-120)</h4>
            <ul style="color:var(--text-muted);font-size:0.85rem;line-height:1.6;padding-left:16px;">
              <li>Q4 bate $12.5B+</li>
              <li>Guidance aumentado para +10%</li>
              <li>PÃ­lula ultrapassa Zepbound oral</li>
              <li>CagriSema fast-track FDA</li>
            </ul>
            <div style="margin-top:8px;color:var(--ok);font-weight:700;">Probabilidade: 30%</div>
          </div>
        </div>

        <div style="padding:16px;background:linear-gradient(135deg, rgba(16,185,129,0.15), rgba(76,201,240,0.15));border-radius:12px;">
          <h3 style="margin-bottom:12px;">ğŸ¯ Meu Price Target: $85 (12 meses)</h3>
          <p style="color:var(--text-muted);line-height:1.7;">
            <strong>Racional:</strong> Com EPS estimado de $4.20 e P/E justo de 20x (ainda desconto vs LLY), 
            o fair value Ã© $84. Com CagriSema aprovado, o P/E pode expandir para 22-25x = $92-105.
          </p>
          <div class="grid grid-4" style="margin-top:16px;gap:12px;">
            <div class="kpi"><div class="value" style="font-size:1.5rem;">$62</div><div class="label">PreÃ§o Atual</div></div>
            <div class="kpi"><div class="value" style="font-size:1.5rem;color:var(--ok);">$85</div><div class="label">Target Base</div></div>
            <div class="kpi"><div class="value" style="font-size:1.5rem;color:var(--accent);">+37%</div><div class="label">Upside</div></div>
            <div class="kpi"><div class="value" style="font-size:1.5rem;color:var(--ok);">BUY</div><div class="label">RecomendaÃ§Ã£o</div></div>
          </div>
        </div>
      </div>

      <!-- Catalysts Calendar Table -->
      <div class="glass">
        <h2>ğŸ“† Catalisadores 2026 - Timeline de Impacto</h2>
        <table class="data-table">
          <thead>
            <tr><th>Data</th><th>Evento</th><th>Impacto PreÃ§o</th><th>Probabilidade</th><th>Status</th></tr>
          </thead>
          <tbody>
            <tr style="background:rgba(251,191,36,0.1);">
              <td><strong>4 Fev 2026</strong></td>
              <td>Q4 2025 Earnings + Guidance 2026</td>
              <td style="font-weight:700;">Â±10-15%</td>
              <td>100%</td>
              <td><span class="badge" style="background:var(--warn);">EM 7 DIAS</span></td>
            </tr>
            <tr>
              <td>Mar-Abr 2026</td>
              <td>Wegovy Pill - Dados 90 dias adoÃ§Ã£o</td>
              <td style="color:var(--ok);">+5-10%</td>
              <td>85%</td>
              <td><span class="badge badge-neutral">AGUARDANDO</span></td>
            </tr>
            <tr>
              <td>Q2 2026</td>
              <td>CagriSema FDA Review Decision</td>
              <td style="color:var(--ok);">+15-25%</td>
              <td>70%</td>
              <td><span class="badge badge-bullish">NDA SUBMETIDO</span></td>
            </tr>
            <tr>
              <td>H1 2026</td>
              <td>Amycretin Fase 3 InÃ­cio</td>
              <td style="color:var(--ok);">+3-5%</td>
              <td>90%</td>
              <td><span class="badge badge-bullish">CONFIRMADO</span></td>
            </tr>
            <tr>
              <td>2026</td>
              <td>Patentes Brasil/China/CanadÃ¡</td>
              <td style="color:var(--bad);">-5-10%</td>
              <td>60%</td>
              <td><span class="badge badge-bearish">RISCO</span></td>
            </tr>
            <tr>
              <td>Q3 2026</td>
              <td>Potencial AquisiÃ§Ã£o/Partnership</td>
              <td style="color:var(--ok);">+10-20%</td>
              <td>30%</td>
              <td><span class="badge badge-neutral">ESPECULATIVO</span></td>
            </tr>
          </tbody>
        </table>
        <div style="margin-top:16px;padding:12px;background:rgba(76,201,240,0.1);border-radius:8px;font-size:0.85rem;color:var(--text-muted);">
          <strong>ğŸ’¡ Nota:</strong> O Q4 Earnings em 4 Fev Ã© o catalisador mais importante do curto prazo. Historicamente, NVO move Â±8-15% apÃ³s earnings.
          CagriSema aprovaÃ§Ã£o Ã© o maior driver de re-rating para mÃºltiplo premium.
        </div>
      </div>
    </div>
    <div id="news" class="tab-content">
      <div class="glass">
        <h2>ğŸ“° NotÃ­cias Recentes e Impacto no PreÃ§o</h2>
        
        <div class="news-item">
          <div class="news-sentiment positive"></div>
          <div style="flex:1;">
            <div class="news-title">Novo Nordisk Regains Spotlight: New Oral Formulation May Have 40% Upside Potential</div>
            <div class="news-meta">28 Jan 2026 â€¢ NAI500 â€¢ Market Analysis</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">Analistas veem potencial de 40% de valorizaÃ§Ã£o com nova formulaÃ§Ã£o oral ganhando traÃ§Ã£o.</p>
          </div>
          <span class="badge badge-bullish">BULLISH</span>
        </div>

        <div class="news-item">
          <div class="news-sentiment positive"></div>
          <div style="flex:1;">
            <div class="news-title">1 Biotech/Pharmaceutical Stock Set to Rebound in 2026</div>
            <div class="news-meta">28 Jan 2026 â€¢ Motley Fool â€¢ Investment Research</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">Novo Nordisk destaca-se como candidata a recuperaÃ§Ã£o forte em 2026 apÃ³s queda de 2025.</p>
          </div>
          <span class="badge badge-bullish">BULLISH</span>
        </div>

        <div class="news-item">
          <div class="news-sentiment positive"></div>
          <div style="flex:1;">
            <div class="news-title">Novo Nordisk A/S Shares Bought by Markel Group Inc.</div>
            <div class="news-meta">28 Jan 2026 â€¢ MarketBeat â€¢ Institutional Activity</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">Compra institucional significativa sinaliza confianÃ§a no valor atual da aÃ§Ã£o.</p>
          </div>
          <span class="badge badge-bullish">BULLISH</span>
        </div>

        <div class="news-item">
          <div class="news-sentiment neutral"></div>
          <div style="flex:1;">
            <div class="news-title">Is Novo Nordisk Pricing Reflect Recent Share Weakness And DCF Upside?</div>
            <div class="news-meta">27 Jan 2026 â€¢ Simply Wall Street â€¢ Valuation Analysis</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">AnÃ¡lise DCF sugere que preÃ§o atual nÃ£o reflete totalmente o valor intrÃ­nseco da empresa.</p>
          </div>
          <span class="badge badge-neutral">ANÃLISE</span>
        </div>

        <div class="news-item">
          <div class="news-sentiment positive"></div>
          <div style="flex:1;">
            <div class="news-title">Wegovy pill had more than 18K prescriptions in first week</div>
            <div class="news-meta">23 Jan 2026 â€¢ Seeking Alpha News</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">Demanda inicial muito forte confirma tese de sucesso da versÃ£o oral.</p>
          </div>
          <span class="badge badge-bullish">BULLISH</span>
        </div>

        <div class="news-item">
          <div class="news-sentiment negative"></div>
          <div style="flex:1;">
            <div class="news-title">Sun Pharma e Dr. Reddy's aprovados para genÃ©ricos na Ãndia</div>
            <div class="news-meta">21-23 Jan 2026 â€¢ Multiple Sources</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">GenÃ©ricos de Ozempic e Wegovy na Ãndia podem pressionar margens futuras.</p>
          </div>
          <span class="badge badge-bearish">RISCO LP</span>
        </div>
      </div>

      <!-- Sentiment Summary -->
      <div class="glass">
        <h2>ğŸ“Š AnÃ¡lise de Sentimento (Ãšltima Semana)</h2>
        <div class="grid grid-3">
          <div class="kpi positive">
            <div class="value">65%</div>
            <div class="label">NotÃ­cias Positivas</div>
          </div>
          <div class="kpi negative">
            <div class="value">20%</div>
            <div class="label">NotÃ­cias Negativas</div>
          </div>
          <div class="kpi warning">
            <div class="value">15%</div>
            <div class="label">Neutras</div>
          </div>
        </div>
        <div style="margin-top:20px;padding:16px;background:rgba(16,185,129,0.1);border-radius:12px;">
          <strong style="color:var(--ok);">ğŸ“ˆ Sentimento Geral: POSITIVO</strong>
          <p style="color:var(--text-muted);margin-top:8px;font-size:0.9rem;">
            A aprovaÃ§Ã£o da pÃ­lula domina o noticiÃ¡rio e estÃ¡ gerando momentum positivo. 
            Riscos de genÃ©ricos sÃ£o de longo prazo e nÃ£o afetam narrativa atual.
          </p>
        </div>
      </div>
    </div>
    <div id="verdict" class="tab-content">
      <!-- Main Verdict -->
      <div class="glass" style="text-align:center;">
        <h2>âš–ï¸ VEREDICTO BRUTALMENTE HONESTO</h2>
        <div class="verdict-box bullish" style="margin:24px 0;">
          <div class="verdict-label">RecomendaÃ§Ã£o</div>
          <div class="verdict-text" style="font-size:2rem;">ğŸ“ˆ COMPRA MODERADA</div>
          <p style="color:var(--text-muted);margin-top:12px;">Risco/Retorno favorÃ¡vel no preÃ§o atual</p>
        </div>
      </div>

      <!-- Bull vs Bear -->
      <div class="grid grid-2">
        <div class="glass" style="border-left:4px solid var(--ok);">
          <h2 style="color:var(--ok);">ğŸ‚ Tese BULL (Por que subir)</h2>
          <ol style="color:var(--text-muted);line-height:2;padding-left:20px;">
            <li><strong>PÃ­lula Ã© GAME CHANGER</strong> - Resolve o maior problema da empresa (supply)</li>
            <li><strong>Valuation atraente</strong> - P/E 17x vs Eli Lilly 52x</li>
            <li><strong>Profitability A+</strong> - Margem lÃ­quida 33%, ROE 71%</li>
            <li><strong>18K prescriÃ§Ãµes na 1Âª semana</strong> - Demanda confirmada</li>
            <li><strong>Novo CEO</strong> - Maziar Doustdar traz energia renovada</li>
            <li><strong>Upside ao 52-week high</strong> - Potencial de +47%</li>
            <li><strong>Dividend yield 2.77%</strong> - Pagamento consistente</li>
          </ol>
        </div>

        <div class="glass" style="border-left:4px solid var(--bad);">
          <h2 style="color:var(--bad);">ğŸ» Tese BEAR (Por que cair)</h2>
          <ol style="color:var(--text-muted);line-height:2;padding-left:20px;">
            <li><strong>CompetiÃ§Ã£o feroz</strong> - Eli Lilly (Zepbound) ganhando share</li>
            <li><strong>GenÃ©ricos chegando</strong> - Ãndia jÃ¡ aprovou (pressÃ£o de preÃ§o)</li>
            <li><strong>CagriSema decepcionou</strong> - Pipeline de prÃ³xima geraÃ§Ã£o incerto</li>
            <li><strong>Processos judiciais</strong> - Caso Teva pode ter impacto</li>
            <li><strong>Beta alto (1.36)</strong> - Volatilidade acima do mercado</li>
            <li><strong>DependÃªncia de GLP-1</strong> - 80%+ da receita em uma classe</li>
            <li><strong>Queda de 55% do pico</strong> - Pode nÃ£o recuperar tudo</li>
          </ol>
        </div>
      </div>

      <!-- Probability -->
      <div class="glass">
        <h2>ğŸ² Probabilidades (AnÃ¡lise Quantitativa)</h2>
        <div class="grid grid-3">
          <div style="text-align:center;">
            <div style="font-size:3rem;margin-bottom:8px;">60%</div>
            <div style="color:var(--ok);font-weight:600;">CenÃ¡rio BULL</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">$80-90 em 12 meses</p>
            <p style="color:var(--text-muted);font-size:0.75rem;">PÃ­lula escala, earnings beats, recupera share</p>
          </div>
          <div style="text-align:center;">
            <div style="font-size:3rem;margin-bottom:8px;">25%</div>
            <div style="color:var(--warn);font-weight:600;">CenÃ¡rio BASE</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">$60-70 em 12 meses</p>
            <p style="color:var(--text-muted);font-size:0.75rem;">Range-bound, competiÃ§Ã£o equilibra ganhos</p>
          </div>
          <div style="text-align:center;">
            <div style="font-size:3rem;margin-bottom:8px;">15%</div>
            <div style="color:var(--bad);font-weight:600;">CenÃ¡rio BEAR</div>
            <p style="color:var(--text-muted);font-size:0.85rem;margin-top:8px;">$40-50 em 12 meses</p>
            <p style="color:var(--text-muted);font-size:0.75rem;">Earnings miss, genÃ©ricos aceleram</p>
          </div>
        </div>
      </div>

      <!-- Final Words -->
      <div class="glass" style="background:linear-gradient(135deg, rgba(0,53,128,0.2), rgba(76,201,240,0.1));">
        <h2>ğŸ“ ConclusÃ£o Final</h2>
        <blockquote style="border-left:4px solid var(--accent);padding-left:20px;margin:16px 0;color:var(--text);font-size:1.1rem;line-height:1.8;">
          "A Novo Nordisk estÃ¡ em um ponto de inflexÃ£o. A aprovaÃ§Ã£o da pÃ­lula Wegovy Ã© genuinamente transformacional 
          e resolve o maior gargalo da empresa. O valuation estÃ¡ atraente comparado a Eli Lilly. 
          <strong>No entanto</strong>, a competiÃ§Ã£o Ã© real e os genÃ©ricos estÃ£o chegando. 
          <br><br>
          <span style="color:var(--ok);">Para investidores com horizonte de 1-3 anos, o risco/retorno Ã© favorÃ¡vel.</span> 
          A empresa tem fundamentos sÃ³lidos (A+ em profitability) e a demanda inicial da pÃ­lula Ã© muito positiva.
          <br><br>
          <span style="color:var(--warn);">Risco principal: Se prÃ³ximos earnings decepcionarem, a aÃ§Ã£o pode voltar aos $50.</span>
        </blockquote>
        <div style="text-align:center;margin-top:20px;">
          <span class="badge badge-bullish" style="font-size:1rem;padding:10px 24px;">VIÃ‰S: MODERADAMENTE OTIMISTA</span>
        </div>
      </div>
    </div>
    <div id="pipeline" class="tab-content">
      <!-- Pipeline Overview -->
      <div class="glass">
        <h2>ğŸ’Š Pipeline de Drogas - AnÃ¡lise de Catalisadores</h2>
        <p style="color:var(--text-muted);margin-bottom:20px;">
          Entender o pipeline Ã© CRUCIAL para prever movimentos futuros da aÃ§Ã£o. Cada aprovaÃ§Ã£o ou fracasso pode mover 5-25%.
        </p>
        
        <div style="overflow-x:auto;">
          <table>
            <tr>
              <th>Droga</th>
              <th>IndicaÃ§Ã£o</th>
              <th>Fase</th>
              <th>Status</th>
              <th>Data Estimada</th>
              <th>Impacto Potencial</th>
            </tr>
            <tr style="background:rgba(16,185,129,0.1);">
              <td><strong>Wegovy (oral)</strong></td>
              <td>Obesidade</td>
              <td><span class="badge badge-bullish">âœ… APROVADO</span></td>
              <td style="color:var(--ok);">FDA Approved Dez/2025</td>
              <td>JÃ¡ no mercado</td>
              <td><span style="color:var(--ok);font-weight:600;">GAME CHANGER</span></td>
            </tr>
            <tr style="background:rgba(16,185,129,0.1);">
              <td><strong>Rybelsus</strong></td>
              <td>Diabetes T2</td>
              <td><span class="badge badge-bullish">âœ… APROVADO</span></td>
              <td style="color:var(--ok);">Comercializado</td>
              <td>-</td>
              <td>Receita estÃ¡vel</td>
            </tr>
            <tr style="background:rgba(251,191,36,0.1);">
              <td><strong>CagriSema</strong></td>
              <td>Obesidade (next-gen)</td>
              <td><span class="badge badge-neutral">NDA Submetido</span></td>
              <td style="color:var(--warn);">FDA review 2026 â€¢ Resultados: 22.7% (vs 25%+ esperado)</td>
              <td>H2 2026</td>
              <td><span style="color:var(--warn);font-weight:600;">CRÃTICO - Sucessor do Wegovy</span></td>
            </tr>
            <tr>
              <td><strong>IcoSema</strong></td>
              <td>Diabetes (1x/semana insulina)</td>
              <td><span class="badge badge-neutral">Fase 3</span></td>
              <td>Resultados pendentes</td>
              <td>Q2 2026</td>
              <td>Alto potencial</td>
            </tr>
            <tr style="background:rgba(76,201,240,0.1);">
              <td><strong>Amycretin</strong></td>
              <td>Obesidade (amylin+GLP-1)</td>
              <td><span class="badge badge-bullish">Fase 3 INICIANDO</span></td>
              <td style="color:var(--ok);">InÃ­cio Fase III anunciado Jan/26</td>
              <td>2027-2028</td>
              <td><span style="color:var(--ok);font-weight:600;">Next-gen candidate</span></td>
            </tr>
            <tr style="background:rgba(248,113,113,0.1);">
              <td><strong>Semaglutide (Alzheimer)</strong></td>
              <td>DoenÃ§a de Alzheimer</td>
              <td><span class="badge badge-bearish">âŒ INTERROMPIDO</span></td>
              <td style="color:var(--bad);">Estudo parado Nov/2025</td>
              <td>-</td>
              <td><span style="color:var(--bad);font-weight:600;">-5.6% no preÃ§o</span></td>
            </tr>
            <tr>
              <td><strong>Wegovy Cardio</strong></td>
              <td>ReduÃ§Ã£o risco CV</td>
              <td><span class="badge badge-bullish">âœ… APROVADO</span></td>
              <td style="color:var(--ok);">Label expansion</td>
              <td>Aprovado 2024</td>
              <td>Amplia mercado</td>
            </tr>
          </table>
        </div>
      </div>

      <!-- Products Revenue -->
      <div class="glass">
        <h2>ğŸ’° Receita por Produto (2025 Est.)</h2>
        <div class="grid grid-2">
          <div>
            <div style="margin-bottom:16px;">
              <div style="display:flex;justify-content:space-between;margin-bottom:4px;">
                <span>Ozempic (Diabetes)</span>
                <span style="font-weight:600;">$21.2B</span>
              </div>
              <div style="height:8px;background:rgba(255,255,255,0.1);border-radius:4px;overflow:hidden;">
                <div style="height:100%;width:52%;background:linear-gradient(90deg,var(--accent),var(--accent-2));border-radius:4px;"></div>
              </div>
            </div>
            <div style="margin-bottom:16px;">
              <div style="display:flex;justify-content:space-between;margin-bottom:4px;">
                <span>Wegovy (Obesidade)</span>
                <span style="font-weight:600;">$8.5B</span>
              </div>
              <div style="height:8px;background:rgba(255,255,255,0.1);border-radius:4px;overflow:hidden;">
                <div style="height:100%;width:21%;background:linear-gradient(90deg,var(--ok),#34d399);border-radius:4px;"></div>
              </div>
            </div>
            <div style="margin-bottom:16px;">
              <div style="display:flex;justify-content:space-between;margin-bottom:4px;">
                <span>Rybelsus (Oral)</span>
                <span style="font-weight:600;">$4.1B</span>
              </div>
              <div style="height:8px;background:rgba(255,255,255,0.1);border-radius:4px;overflow:hidden;">
                <div style="height:100%;width:10%;background:linear-gradient(90deg,var(--warn),#fcd34d);border-radius:4px;"></div>
              </div>
            </div>
            <div style="margin-bottom:16px;">
              <div style="display:flex;justify-content:space-between;margin-bottom:4px;">
                <span>Outros (Insulinas, etc.)</span>
                <span style="font-weight:600;">$6.8B</span>
              </div>
              <div style="height:8px;background:rgba(255,255,255,0.1);border-radius:4px;overflow:hidden;">
                <div style="height:100%;width:17%;background:rgba(255,255,255,0.3);border-radius:4px;"></div>
              </div>
            </div>
          </div>
          <div style="display:flex;flex-direction:column;justify-content:center;align-items:center;padding:20px;background:rgba(0,53,128,0.2);border-radius:16px;">
            <div style="font-size:0.8rem;color:var(--text-muted);margin-bottom:8px;">RECEITA TOTAL 2025E</div>
            <div style="font-size:2.5rem;font-weight:700;">$40.6B</div>
            <div style="color:var(--ok);margin-top:8px;">+18% YoY</div>
          </div>
        </div>
      </div>

      <!-- Key Catalysts -->
      <div class="glass">
        <h2>ğŸ¯ PrÃ³ximos Catalisadores (Datas para Ficar de Olho)</h2>
        <div class="grid grid-3">
          <div style="padding:16px;background:linear-gradient(135deg, rgba(251,191,36,0.15), rgba(251,191,36,0.05));border-radius:12px;border-left:4px solid var(--warn);">
            <div style="font-size:0.75rem;color:var(--warn);text-transform:uppercase;letter-spacing:1px;">ğŸ“… 4 Fev 2026</div>
            <div style="font-weight:600;margin:8px 0;">Q4 2025 Earnings</div>
            <div style="font-size:0.85rem;color:var(--text-muted);">Primeiro resultado com receita da pÃ­lula Wegovy</div>
          </div>
          <div style="padding:16px;background:linear-gradient(135deg, rgba(76,201,240,0.15), rgba(76,201,240,0.05));border-radius:12px;border-left:4px solid var(--accent);">
            <div style="font-size:0.75rem;color:var(--accent);text-transform:uppercase;letter-spacing:1px;">ğŸ“… Q2 2026</div>
            <div style="font-weight:600;margin:8px 0;">IcoSema Resultados</div>
            <div style="font-size:0.85rem;color:var(--text-muted);">Insulina semanal - pode ser outro blockbuster</div>
          </div>
          <div style="padding:16px;background:linear-gradient(135deg, rgba(16,185,129,0.15), rgba(16,185,129,0.05));border-radius:12px;border-left:4px solid var(--ok);">
            <div style="font-size:0.75rem;color:var(--ok);text-transform:uppercase;letter-spacing:1px;">ğŸ“… 2026-2027</div>
            <div style="font-weight:600;margin:8px 0;">ExpansÃ£o China/Ãndia</div>
            <div style="font-size:0.85rem;color:var(--text-muted);">Mercados emergentes = prÃ³ximo motor de crescimento</div>
          </div>
        </div>
      </div>

      <!-- Competition Analysis -->
      <div class="glass">
        <h2>âš”ï¸ Batalha GLP-1: NVO vs LLY (Resultados 4 Fev)</h2>
        <p style="color:var(--text-muted);margin-bottom:16px;"><strong>AMBAS reportam no mesmo dia!</strong> ComparaÃ§Ã£o direta dos resultados Q4 2025.</p>
        <div class="grid grid-2">
          <div style="padding:20px;background:rgba(0,53,128,0.2);border-radius:16px;border:1px solid rgba(0,53,128,0.3);">
            <div style="text-align:center;margin-bottom:16px;">
              <div style="font-size:1.5rem;margin-bottom:4px;">ğŸ‡©ğŸ‡°</div>
              <div style="font-weight:700;font-size:1.2rem;">NOVO NORDISK</div>
              <div style="font-size:0.8rem;color:var(--text-muted);">"OpÃ§Ã£o de Valor"</div>
            </div>
            <table style="font-size:0.85rem;">
              <tr><td style="color:var(--text-muted);">EPS Est. Q4</td><td>$0.89-0.90</td></tr>
              <tr><td style="color:var(--text-muted);">Receita Est.</td><td>~$12B</td></tr>
              <tr><td style="color:var(--text-muted);">Crescimento</td><td style="color:var(--warn);">EstÃ¡vel</td></tr>
              <tr><td style="color:var(--text-muted);">Vendas 2026</td><td>$39.5B</td></tr>
              <tr><td style="color:var(--text-muted);">P/E Forward</td><td style="color:var(--ok);">18x</td></tr>
              <tr><td style="color:var(--text-muted);">PÃ­lula Oral</td><td style="color:var(--ok);">âœ… LanÃ§ada</td></tr>
              <tr><td style="color:var(--text-muted);">DiversificaÃ§Ã£o</td><td style="color:var(--bad);">6% (94% GLP-1)</td></tr>
            </table>
          </div>
          <div style="padding:20px;background:rgba(248,113,113,0.1);border-radius:16px;border:1px solid rgba(248,113,113,0.2);">
            <div style="text-align:center;margin-bottom:16px;">
              <div style="font-size:1.5rem;margin-bottom:4px;">ğŸ‡ºğŸ‡¸</div>
              <div style="font-weight:700;font-size:1.2rem;">ELI LILLY</div>
              <div style="font-size:0.8rem;color:var(--text-muted);">"OpÃ§Ã£o de Crescimento"</div>
            </div>
            <table style="font-size:0.85rem;">
              <tr><td style="color:var(--text-muted);">EPS Est. Q4</td><td style="color:var(--ok);">$7.11-7.48</td></tr>
              <tr><td style="color:var(--text-muted);">Receita Est.</td><td style="color:var(--ok);">$17.85B</td></tr>
              <tr><td style="color:var(--text-muted);">Crescimento</td><td style="color:var(--ok);">+32% YoY</td></tr>
              <tr><td style="color:var(--text-muted);">Vendas 2026</td><td style="color:var(--ok);">$45B</td></tr>
              <tr><td style="color:var(--text-muted);">P/E Forward</td><td style="color:var(--bad);">32.5x</td></tr>
              <tr><td style="color:var(--text-muted);">PÃ­lula Oral</td><td style="color:var(--warn);">Orforglipron (pending)</td></tr>
              <tr><td style="color:var(--text-muted);">DiversificaÃ§Ã£o</td><td style="color:var(--ok);">Oncologia, Alzheimer</td></tr>
            </table>
          </div>
        </div>
        <div style="margin-top:20px;padding:16px;background:rgba(251,191,36,0.1);border-radius:12px;">
          <strong style="color:var(--warn);">ğŸ“Š Estudo SURMOUNT-5:</strong>
          <span style="color:var(--text-muted);"> Zepbound (LLY) supera Wegovy: <strong>25% mais pacientes</strong> perderam >15% do peso corporal.</span>
        </div>
        <div style="margin-top:12px;padding:16px;background:rgba(76,201,240,0.1);border-radius:12px;text-align:center;">
          <strong>ğŸ¯ Upside Potencial:</strong> NVO <span style="color:var(--ok);">+53%</span> vs LLY <span style="color:var(--accent);">+31%</span> (WSJ Consensus)
        </div>
      </div>
    </div>
    <div id="data" class="tab-content">
      <!-- Company Profile -->
      <div class="glass">
        <h2>ğŸ¢ Perfil da Empresa</h2>
        <div class="grid grid-2">
          <div>
            <table>
              <tr><td style="color:var(--text-muted);">Nome</td><td>Novo Nordisk A/S</td></tr>
              <tr><td style="color:var(--text-muted);">FundaÃ§Ã£o</td><td>1923 (102 anos)</td></tr>
              <tr><td style="color:var(--text-muted);">Sede</td><td>Bagsvaerd, Dinamarca</td></tr>
              <tr><td style="color:var(--text-muted);">CEO</td><td>Maziar Doustdar (desde 2025)</td></tr>
              <tr><td style="color:var(--text-muted);">FuncionÃ¡rios</td><td>~78,554</td></tr>
              <tr><td style="color:var(--text-muted);">Setor</td><td>Healthcare / Pharmaceuticals</td></tr>
            </table>
          </div>
          <div>
            <table>
              <tr><td style="color:var(--text-muted);">Segmentos</td><td>Diabetes & Obesity (90%+), Rare Disease</td></tr>
              <tr><td style="color:var(--text-muted);">Produtos Principais</td><td>Ozempic, Wegovy, Rybelsus, Saxenda</td></tr>
              <tr><td style="color:var(--text-muted);">Brasil</td><td>FÃ¡brica em Montes Claros (MG) - 25% insulina global</td></tr>
              <tr><td style="color:var(--text-muted);">Website</td><td>novonordisk.com</td></tr>
              <tr><td style="color:var(--text-muted);">BDR</td><td>N1VO34 (B3)</td></tr>
              <tr><td style="color:var(--text-muted);">ADR</td><td>NVO (NYSE)</td></tr>
            </table>
          </div>
        </div>
      </div>

      <!-- Financial Data -->
      <div class="glass">
        <h2>ğŸ’µ Dados Financeiros</h2>
        <div class="grid grid-4">
          <div class="kpi">
            <div class="value">$209.6B</div>
            <div class="label">Market Cap</div>
          </div>
          <div class="kpi">
            <div class="value">$225B</div>
            <div class="label">Enterprise Value</div>
          </div>
          <div class="kpi">
            <div class="value">$15.9B</div>
            <div class="label">Total Debt</div>
          </div>
          <div class="kpi">
            <div class="value">$5.1B</div>
            <div class="label">Cash</div>
          </div>
        </div>
        <div class="grid grid-4" style="margin-top:20px;">
          <div class="kpi">
            <div class="value">83.4%</div>
            <div class="label">Gross Margin</div>
          </div>
          <div class="kpi">
            <div class="value">48.7%</div>
            <div class="label">EBIT Margin</div>
          </div>
          <div class="kpi">
            <div class="value">32.9%</div>
            <div class="label">Net Margin</div>
          </div>
          <div class="kpi">
            <div class="value">20.3%</div>
            <div class="label">ROA</div>
          </div>
        </div>
      </div>

      <!-- Dividend Data -->
      <div class="glass">
        <h2>ğŸ’° Dividendos</h2>
        <div class="grid grid-4">
          <div class="kpi">
            <div class="value">2.77%</div>
            <div class="label">Dividend Yield</div>
          </div>
          <div class="kpi">
            <div class="value">$1.73</div>
            <div class="label">Payout Anual (TTM)</div>
          </div>
          <div class="kpi">
            <div class="value">52.4%</div>
            <div class="label">Payout Ratio</div>
          </div>
          <div class="kpi positive">
            <div class="value">6 anos</div>
            <div class="label">Anos de Crescimento</div>
          </div>
        </div>
        <p style="color:var(--text-muted);margin-top:16px;font-size:0.85rem;">
          ğŸ“… PrÃ³ximo dividendo: $0.58 | Ex-date: 18/08/2025 | Pagamento: 26/08/2025 | FrequÃªncia: Semestral
        </p>
      </div>

      <!-- Price History Table -->
      <div class="glass">
        <h2>ğŸ“Š HistÃ³rico de PreÃ§os (Ãšltimos 12 meses)</h2>
        <div style="overflow-x:auto;">
          <table>
            <tr>
              <th>Data</th><th>PreÃ§o (USD)</th><th>VariaÃ§Ã£o</th><th>Volume</th><th>Evento</th>
            </tr>
            <tr><td>26/Jan/26</td><td>$63.60</td><td style="color:var(--ok);">+2.15%</td><td>13.5M</td><td>Momentum pÃ³s-earnings preview</td></tr>
            <tr><td>23/Dez/25</td><td>$51.61</td><td style="color:var(--ok);">+7.3%</td><td>67.6M</td><td>ğŸ‰ FDA aprova pÃ­lula Wegovy</td></tr>
            <tr><td>24/Nov/25</td><td>$44.97</td><td style="color:var(--bad);">-5.6%</td><td>73.6M</td><td>Estudo Alzheimer interrompido</td></tr>
            <tr><td>29/Jul/25</td><td>$53.94</td><td style="color:var(--bad);">-24.8%</td><td>110.7M</td><td>ğŸ’¥ CagriSema decepciona</td></tr>
            <tr><td>06/Ago/25</td><td>$45.38</td><td style="color:var(--bad);">-4%</td><td>37.4M</td><td>MÃ­nima do ano</td></tr>
            <tr><td>21/Fev/25</td><td>$88.08</td><td style="color:var(--ok);">+5.2%</td><td>15.1M</td><td>RecuperaÃ§Ã£o tÃ©cnica</td></tr>
            <tr><td>Mar/24</td><td>$140+</td><td>ATH</td><td>-</td><td>ğŸ† Pico histÃ³rico - Maior da Europa</td></tr>
          </table>
        </div>
      </div>

      <!-- Competitors -->
      <div class="glass">
        <h2>ğŸ†š Comparativo com Concorrentes</h2>
        <table>
          <tr>
            <th>Empresa</th><th>Ticker</th><th>Market Cap</th><th>P/E</th><th>Margem</th><th>Produto GLP-1</th>
          </tr>
          <tr>
            <td><strong>Novo Nordisk</strong></td><td>NVO</td><td>$209.6B</td><td>16.7x</td><td>33%</td><td>Ozempic, Wegovy, Rybelsus</td>
          </tr>
          <tr>
            <td>Eli Lilly</td><td>LLY</td><td>$950B</td><td>52x</td><td>18%</td><td>Mounjaro, Zepbound</td>
          </tr>
          <tr>
            <td>Pfizer</td><td>PFE</td><td>$145B</td><td>10x</td><td>15%</td><td>Danuglipron (em desenvolvimento)</td>
          </tr>
          <tr>
            <td>AstraZeneca</td><td>AZN</td><td>$220B</td><td>35x</td><td>20%</td><td>Parceria com Eccogene</td>
          </tr>
        </table>
      </div>
    </div>
  </div>

  <script>
    // Language Toggle
    let currentLang = localStorage.getItem('lang') || 'pt';
    function setLang(lang) {
      currentLang = lang;
      localStorage.setItem('lang', lang);
      document.querySelectorAll('.lang-btn').forEach(btn => btn.classList.remove('active'));
      document.querySelector(`.lang-btn[onclick="setLang('${lang}')"]`).classList.add('active');
      document.querySelectorAll('[data-pt][data-en]').forEach(el => { el.textContent = el.getAttribute(`data-${lang}`); });
    }
    // Init language
    document.addEventListener('DOMContentLoaded', () => setLang(currentLang));

    // Theme Toggle
    function toggleTheme() {
      const current = document.documentElement.getAttribute('data-theme');
      const next = current === 'light' ? 'dark' : 'light';
      document.documentElement.setAttribute('data-theme', next);
      localStorage.setItem('nvo-theme', next);
      updateChartsTheme(next);
    }
    // Load saved theme
    const savedTheme = localStorage.getItem('nvo-theme');
    if (savedTheme) document.documentElement.setAttribute('data-theme', savedTheme);

    // Tab Navigation
    document.querySelectorAll('.tab-btn').forEach(btn => {
      btn.addEventListener('click', () => {
        document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
        document.querySelectorAll('.tab-content').forEach(t => t.classList.remove('active'));
        btn.classList.add('active');
        document.getElementById(btn.dataset.tab).classList.add('active');
      });
    });

    // Update timestamp
    function updateTime() {
      const now = new Date();
      document.getElementById('lastUpdate').textContent = now.toLocaleString('pt-BR');
    }
    updateTime();
    setInterval(updateTime, 60000);

    // Price Data
    const priceData = {
      labels: ['Jan/25','Fev/25','Mar/25','Abr/25','Mai/25','Jun/25','Jul/25','Ago/25','Set/25','Out/25','Nov/25','Dez/25','Jan/26'],
      prices: [87.51, 90.65, 69.44, 62.55, 71.50, 69.02, 47.07, 45.38, 55.49, 49.46, 44.97, 51.61, 62.89],
      events: [
        { idx: 0, text: 'Alta inicial', type: 'neutral' },
        { idx: 2, text: 'Tariffs Fear', type: 'negative' },
        { idx: 4, text: 'RecuperaÃ§Ã£o tÃ©cnica', type: 'positive' },
        { idx: 6, text: 'CagriSema decepciona -34%', type: 'negative' },
        { idx: 7, text: 'MÃ­nima do ano $45.38', type: 'negative' },
        { idx: 10, text: 'Alzheimer estudo parado', type: 'negative' },
        { idx: 11, text: 'FDA aprova pÃ­lula +7%', type: 'positive' },
        { idx: 12, text: 'RecuperaÃ§Ã£o continua', type: 'positive' }
      ]
    };

    // 3 Stocks Data (normalized % returns)
    const threeStocksData = {
      labels: ['Jan/25','Fev/25','Mar/25','Abr/25','Mai/25','Jun/25','Jul/25','Ago/25','Set/25','Out/25','Nov/25','Dez/25','Jan/26'],
      nvo: [0, 3.6, -20.7, -28.5, -18.3, -21.1, -46.2, -48.1, -36.6, -43.5, -48.6, -41.0, -28.1],
      novob: [0, 4.1, -19.8, -27.2, -17.5, -20.3, -45.1, -47.8, -35.9, -42.8, -47.5, -40.2, -33.5],
      n1vo34: [0, 5.2, -18.5, -26.1, -16.8, -19.7, -44.2, -46.9, -34.8, -41.5, -46.2, -38.9, -31.8]
    };

    // Predictive Data
    const predictiveData = {
      labels: ['Jan/26','Fev/26','Mar/26','Abr/26','Mai/26','Jun/26','Jul/26','Ago/26','Set/26','Out/26','Nov/26','Dez/26'],
      actual: [62.89, null, null, null, null, null, null, null, null, null, null, null],
      bull: [62.89, 68, 72, 78, 82, 85, 88, 92, 95, 98, 102, 110],
      base: [62.89, 64, 66, 68, 70, 72, 70, 72, 74, 76, 78, 82],
      bear: [62.89, 58, 54, 50, 48, 45, 42, 44, 46, 48, 50, 52]
    };

    // Chart.js defaults
    Chart.defaults.color = '#94a3b8';
    Chart.defaults.borderColor = 'rgba(255,255,255,0.05)';

    // Price Chart
    const priceCtx = document.getElementById('priceChart').getContext('2d');
    const priceChart = new Chart(priceCtx, {
      type: 'line',
      data: {
        labels: priceData.labels,
        datasets: [{
          label: 'NVO (USD)',
          data: priceData.prices,
          borderColor: '#4cc9f0',
          backgroundColor: 'rgba(76,201,240,0.1)',
          fill: true,
          tension: 0.3,
          pointRadius: 5,
          pointBackgroundColor: priceData.prices.map((p, i) => {
            const evt = priceData.events.find(e => e.idx === i);
            if (evt) {
              if (evt.type === 'positive') return '#10b981';
              if (evt.type === 'negative') return '#f87171';
              return '#fbbf24';
            }
            return '#4cc9f0';
          }),
          pointBorderColor: '#fff',
          pointBorderWidth: 2
        }]
      },
      options: {
        responsive: true,
        maintainAspectRatio: false,
        plugins: {
          legend: { display: false },
          tooltip: {
            callbacks: {
              afterLabel: function(context) {
                const evt = priceData.events.find(e => e.idx === context.dataIndex);
                return evt ? 'ğŸ“Œ ' + evt.text : '';
              }
            }
          }
        },
        scales: {
          y: { grid: { color: 'rgba(255,255,255,0.05)' }, ticks: { callback: v => '$' + v } },
          x: { grid: { color: 'rgba(255,255,255,0.05)' } }
        }
      }
    });

    // 3 Stocks Chart
    const threeCtx = document.getElementById('threeStocksChart').getContext('2d');
    const threeStocksChart = new Chart(threeCtx, {
      type: 'line',
      data: {
        labels: threeStocksData.labels,
        datasets: [
          { label: 'ğŸ‡ºğŸ‡¸ NVO (NYSE)', data: threeStocksData.nvo, borderColor: '#4cc9f0', backgroundColor: 'rgba(76,201,240,0.1)', fill: false, tension: 0.3 },
          { label: 'ğŸ‡©ğŸ‡° NOVO-B (CPH)', data: threeStocksData.novob, borderColor: '#667eea', backgroundColor: 'rgba(102,126,234,0.1)', fill: false, tension: 0.3 },
          { label: 'ğŸ‡§ğŸ‡· N1VO34 (B3)', data: threeStocksData.n1vo34, borderColor: '#10b981', backgroundColor: 'rgba(16,185,129,0.1)', fill: false, tension: 0.3 }
        ]
      },
      options: {
        responsive: true,
        maintainAspectRatio: false,
        plugins: { legend: { position: 'top', labels: { usePointStyle: true } } },
        scales: {
          y: { grid: { color: 'rgba(255,255,255,0.05)' }, ticks: { callback: v => v + '%' } },
          x: { grid: { color: 'rgba(255,255,255,0.05)' } }
        }
      }
    });

    // Predictive Chart
    const predCtx = document.getElementById('predictiveChart').getContext('2d');
    const predictiveChart = new Chart(predCtx, {
      type: 'line',
      data: {
        labels: predictiveData.labels,
        datasets: [
          { label: 'PreÃ§o Atual', data: predictiveData.actual, borderColor: '#4cc9f0', backgroundColor: '#4cc9f0', pointRadius: 8, pointStyle: 'circle', fill: false },
          { label: 'ğŸ‚ Bull Case (45%)', data: predictiveData.bull, borderColor: '#10b981', borderDash: [5,5], fill: false, tension: 0.3 },
          { label: 'ğŸ“Š Base Case (25%)', data: predictiveData.base, borderColor: '#fbbf24', borderDash: [5,5], fill: false, tension: 0.3 },
          { label: 'ğŸ» Bear Case (15%)', data: predictiveData.bear, borderColor: '#f87171', borderDash: [5,5], fill: false, tension: 0.3 }
        ]
      },
      options: {
        responsive: true,
        maintainAspectRatio: false,
        plugins: { legend: { position: 'top', labels: { usePointStyle: true } } },
        scales: {
          y: { grid: { color: 'rgba(255,255,255,0.05)' }, ticks: { callback: v => '$' + v }, min: 30, max: 120 },
          x: { grid: { color: 'rgba(255,255,255,0.05)' } }
        }
      }
    });

    // Update charts for theme
    function updateChartsTheme(theme) {
      const gridColor = theme === 'light' ? 'rgba(0,0,0,0.1)' : 'rgba(255,255,255,0.05)';
      const textColor = theme === 'light' ? '#334155' : '#94a3b8';
      [priceChart, threeStocksChart, predictiveChart].forEach(chart => {
        if (chart) {
          chart.options.scales.x.grid.color = gridColor;
          chart.options.scales.y.grid.color = gridColor;
          chart.options.scales.x.ticks.color = textColor;
          chart.options.scales.y.ticks.color = textColor;
          chart.update();
        }
      });
    }
    // Apply theme to charts on load
    if (savedTheme) updateChartsTheme(savedTheme);

    // =========================================
    // REAL-TIME STOCK API (Yahoo Finance)
    // =========================================
    async function fetchStockPrices() {
      const symbols = ['NVO', 'NOVO-B.CO', 'N1VO34.SA'];
      const proxyUrl = 'https://api.allorigins.win/raw?url=';
      
      for (const symbol of symbols) {
        try {
          const yahooUrl = `https://query1.finance.yahoo.com/v8/finance/chart/${symbol}?interval=1d&range=1d`;
          const response = await fetch(proxyUrl + encodeURIComponent(yahooUrl));
          const data = await response.json();
          
          if (data.chart && data.chart.result && data.chart.result[0]) {
            const result = data.chart.result[0];
            const meta = result.meta;
            const price = meta.regularMarketPrice;
            const prevClose = meta.previousClose || meta.chartPreviousClose;
            const change = price - prevClose;
            const changePercent = ((change / prevClose) * 100).toFixed(2);
            const currency = meta.currency;
            
            updatePriceCard(symbol, price, change, changePercent, currency);
          }
        } catch (error) {
          console.log(`Erro ao buscar ${symbol}:`, error.message);
        }
      }
      
      // Update timestamp
      const now = new Date();
      const timeStr = now.toLocaleTimeString('pt-BR', { hour: '2-digit', minute: '2-digit' });
      document.querySelector('.live-badge').innerHTML = `<span style="width:8px;height:8px;background:var(--ok);border-radius:50%;animation:pulse 2s infinite;"></span> LIVE ${timeStr}`;
    }

    function updatePriceCard(symbol, price, change, changePercent, currency) {
      let priceEl, changeEl, currencySymbol;
      
      if (symbol === 'NVO') {
        priceEl = document.getElementById('priceUSD');
        changeEl = document.getElementById('changeUSD');
        currencySymbol = '$';
      } else if (symbol === 'NOVO-B.CO') {
        priceEl = document.getElementById('priceDKK');
        changeEl = document.getElementById('changeDKK');
        currencySymbol = 'kr.';
      } else if (symbol === 'N1VO34.SA') {
        priceEl = document.getElementById('priceBRL');
        changeEl = document.getElementById('changeBRL');
        currencySymbol = 'R$';
      }
      
      if (priceEl && changeEl) {
        priceEl.textContent = `${currencySymbol}${price.toFixed(2)}`;
        
        const isPositive = change >= 0;
        changeEl.textContent = `${isPositive ? '+' : ''}${currencySymbol}${change.toFixed(2)} (${isPositive ? '+' : ''}${changePercent}%)`;
        changeEl.className = `change ${isPositive ? 'up' : 'down'}`;
      }
    }

    // Fetch on load
    fetchStockPrices();
    
    // Refresh every 5 minutes
    setInterval(fetchStockPrices, 5 * 60 * 1000);
  </script>
</body>
</html>
